elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58724935-D5D0FAEE-744A-4ECB-911D-E0C9E422E45A
Q58724935-D5D0FAEE-744A-4ECB-911D-E0C9E422E45A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58724935-D5D0FAEE-744A-4ECB-911D-E0C9E422E45A
Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
P2860
Q58724935-D5D0FAEE-744A-4ECB-911D-E0C9E422E45A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58724935-D5D0FAEE-744A-4ECB-911D-E0C9E422E45A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5cd79c57c595af97971f3cf8a637ef5a2a275732
P2860
Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.